Obstetrics & Gynecology Science

Gynecologic Oncology
The evolving landscape of immunohistochemistry in cervical and uterine carcinoma in gynecologic oncology: current status and future directions: Sumedha Gupta, Sana Ahuja, Dheer Singh Kalwaniya; Obstet Gynecol Sci. 2024;67(5):449-466. Published online September 4, 2024; DOI: https://doi.org/10.5468/ogs.24120; Full text PubReader ePub PDF

Pretreatment total lymphocyte count as a prognostic factor of survival in patients with recurrent cervical cancer after definitive radiation-based therapy: a retrospective study: Ekasak Thiangphak, Kittinun Leetanaporn, Rakchai Buhachat; Obstet Gynecol Sci. 2023;66(5):407-416. Published online July 19, 2023; DOI: https://doi.org/10.5468/ogs.23119
Web of Science 1 Crossref 2; Full text PubReader ePub PDF Supplementary Material

General Gynecology
Surgical outcomes of laparoscopic trachelectomy following supracervical hysterectomy: a multicenter study: Ayman Shehata Dawood, Heba Fouad Harras, Hossam Ramadan Moussa, Ahmed Saber Soliman; Obstet Gynecol Sci. 2022;65(6):542-551. Published online November 10, 2022; DOI: https://doi.org/10.5468/ogs.22094
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Gynecologic Oncology
Clinical outcomes of immunohistochemistry of the p53 Staining pattern in high-grade serous ovarian carcinoma: Panarat Orachum, Amornrat Temtanakitpaisan, Pilaiwan Kleebkaow, Bandit Chumworathayi, Sanguanchoke Luanratanakorn, Apiwat Aue-angkul, Yuwadee Itarat; Obstet Gynecol Sci. 2022;65(5):459-467. Published online July 29, 2022; DOI: https://doi.org/10.5468/ogs.22102
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Incidence and predictive factors for recurrent clear cell ovarian carcinoma: results from a single center in Thailand: Wikanda Hemman, Athithan Rattanaburi; Obstet Gynecol Sci. 2022;65(2):188-196. Published online February 23, 2022; DOI: https://doi.org/10.5468/ogs.21313
Web of Science 2 Crossref 2; Full text PubReader ePub PDF Supplementary Material

The baseline recurrence risk of patients with intermediate-risk cervical cancer: Yutaka Yoneoka, Mayumi Kobayashi Kato, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Takashi Murakami, Tomoyasu Kato; Obstet Gynecol Sci. 2021;64(2):226-233. Published online January 8, 2021; DOI: https://doi.org/10.5468/ogs.20243
Web of Science 3 Crossref 4; Full text PubReader ePub PDF Supplementary Material

A case of endometrial glassy cell carcinoma: a rare entity which necessitates of better understanding: Clelia Callegari, Paola Algeri, Antonella Buzzi, Teresio Motta, Cinzia Manfredini, Sonia Maria Rota; Obstet Gynecol Sci. 2019;62(6):478-482. Published online October 28, 2019; DOI: https://doi.org/10.5468/ogs.2019.62.6.478
Crossref 3; Full text PubReader ePub PDF

A case of extremely early cervical adenocarcinoma diagnosed only by endocervical curettage with macroscopic pelvic lymph node metastases: Jae Hak Jung, Byoung Ryun Kim; Obstet Gynecol Sci. 2019;62(6):483-486. Published online October 24, 2019; DOI: https://doi.org/10.5468/ogs.2019.62.6.483
Crossref 2; Full text PubReader ePub PDF

A rare case of gastric-type mucinous adenocarcinoma in a woman with Peutz-Jeghers syndrome: Yeorae Kim, Eun Yi Kim, Tae Jin Kim, Kyung Taek Lim, Ki Heon Lee, Yikyeong Chun, Kyeong A So; Obstet Gynecol Sci. 2019;62(6):474-477. Published online October 11, 2019; DOI: https://doi.org/10.5468/ogs.2019.62.6.474
Crossref 5; Full text PubReader ePub PDF

Different expression of GSK3β and pS9GSK3β depending on phenotype of cervical cancer: possible association of GSK3β with squamous cell carcinoma and pS9GSK3β with adenocarcinoma: Kwanghee Ahn, Sojung Kweon, Dae Woon Kim, Hojung Lee; Obstet Gynecol Sci. 2019;62(3):157-165. Published online April 12, 2019; DOI: https://doi.org/10.5468/ogs.2019.62.3.157
Crossref 3; Full text PubReader ePub PDF

A rare case of squamous cell carcinoma in situ arising in mature cystic teratoma: Hee Kang Kyeong, Hye Rim Ku, Chang-Woon Kim, Eun Jin Heo; Obstet Gynecol Sci. 2018;61(5):631-635. Published online September 4, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.5.631
Crossref 1; Full text PubReader PDF

Gynecologic Oncology
Minimal deviation adenocarcinoma (adenoma malignum) of the uterine cervix: clinicopathological analysis of 17 cases: Min Hee Lee, Eun Soo Kim, Min Chul Choi, Jin-Hyung Heo, Ja-Hyun Jang, Sang Geun Jung, Hyun Park, Won Duk Joo, Chan Lee, Je Ho Lee; Obstet Gynecol Sci. 2018;61(5):590-597. Published online August 28, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.5.590
Crossref 9; Full text PubReader PDF

Effect of tibolone on the survival of early stage cervical adenocarcinoma patients: Seung-Ho Lee, Yoon-Jin Cho, Kyung-Joo Cho, Mee-Hyang Ko, Sun-Young Jung, Seung-Joo Chon, So-Yi Lim, Kwang-Beom Lee; Obstet Gynecol Sci. 2018;61(5):584-589. Published online August 7, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.5.584
Crossref 3; Full text PubReader PDF

Gynecologic Oncology
Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas: Ji Hui Choi, Geum Seon Sohn, Doo Byung Chay, Han Byoul Cho, Jae-Hoon Kim; Obstet Gynecol Sci. 2018;61(3):344-351. Published online May 2, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.3.344
Crossref 16; Full text PubReader PDF

Optimal cutoff level of serum squamous cell carcinoma antigen to detect recurrent cervical squamous cell carcinoma during post-treatment surveillance: Jinju Oh, Jin Young Bae; Obstet Gynecol Sci. 2018;61(3):337-343. Published online April 23, 2018; DOI: https://doi.org/10.5468/ogs.2018.61.3.337
Crossref 9; Full text PubReader PDF

Search